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Rapidly treating infections with adequate antibiotics is of major importance. This requires
a fast and accurate determination of the antibiotic susceptibility of bacterial pathogens.
Themost frequently usedmethods are slow because they are based on themeasurement
of growth inhibition. Faster methods, such as PCR-based detection of determinants
of antibiotic resistance, do not always provide relevant information on susceptibility,
particularly that which is not genetically based. Consequently, new methods, such
as the detection of changes in bacterial physiology caused by antibiotics using flow
cytometry and fluorescent viability markers, are being explored. In this study, we
assessed whether Alexa Fluor® 633 Hydrazide (AFH), which targets carbonyl groups,
can be used for antibiotic susceptibility testing. Carbonylation of cellular macromolecules,
which increases in antibiotic-treated cells, is a particularly appropriate to assess for
this purpose because it is irreversible. We tested the susceptibility of clinical isolates
of Gram-negative bacteria, Escherichia coli and Pseudomonas aeruginosa, to antibiotics
from the three classes: β-lactams, aminoglycosides, and fluoroquinolones. In addition to
AFH, we used TO-PRO®-3, which enters cells with damaged membranes and binds
to DNA, and DiBAC4 (3), which enters cells with depolarized membranes. We also
monitored antibiotic-inducedmorphological alterations of bacterial cells by analyzing light
scattering signals. Although all tested dyes and light scattering signals allowed for the
detection of antibiotic-sensitive cells, AFH proved to be the most suitable for the fast and
reliable detection of antibiotic susceptibility.
Keywords: flow cytometry, antibiotic susceptibility testing, protein carbonylation, fluorescent hydrazide, bacteria
INTRODUCTION
Treating bacterial infections with an appropriate antibiotic is of the utmost importance. A
systematic review and meta-analysis revealed that the percentage of in-hospital inappropriate
empiric antibiotic use ranged from 14 to 79% (Marquet et al., 2015). Inappropriate antibiotic
treatments considerably increase morbidity and mortality rates, even if the patient receives an
appropriate antibiotic as a second line therapy (Davey and Marwick, 2008; Marquet et al.,
2015). Inappropriate antibiotic treatments needlessly expose patients to unwanted side effects and
contribute to the increase in the appearance and spread of multidrug resistance (Kohanski et al.,
2010). Consequently, inappropriate antibiotic therapies are significantly contributing to an increase
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in healthcare costs that are already high. The inappropriate
utilization of antibiotics also decreases their effective lifespan,
which is of major concern because of a shortage in the discovery
of new antibiotics mostly due to the lack of interest of the
pharmaceutical industry (Fair and Tor, 2014). Consequently,
there is a lack of promising candidate compounds that passed
clinical trials.
Fast and accurate antibiotic susceptibility tests can
significantly reduce mortality rates and reduce financial
costs (Barenfanger et al., 1999). Furthermore, the necessity of
rapidly prescribing an initial empirical antimicrobial treatment
while waiting for the susceptibility test results from time—
consuming standard methods frequently leads to inappropriate
treatments (Ibrahim et al., 2000). The standard methods of
antibiotic susceptibility testing (AST) are based on measuring
the inhibition of bacterial growth. Consequently, the average
times required to obtain a result are∼18–24 h for the most rapid
systems. Standard techniques include the broth microdilution
reference method, as well as manual and automated alternative
methods, such as Etest R©, VITEK 2 (bioMérieux, Marcy l’Etoile,
France) and disk diffusion (Eigner et al., 2005; Courvalin et al.,
2009). Most of these methods also measure the minimum
concentration of an antibiotic that is able to inhibit the growth
of a bacterial strain. This value, referred to as the minimum
inhibitory concentration (MIC), was first defined in the
mid-1940s (Wheat, 2001).
In the last two decades, faster AST methods, such as
DNA-based tests (Barken et al., 2007) and mass spectrometry-
based methods (Opota et al., 2015; Trip et al., 2015), have
been developed. However, they do not always provide relevant
information on antibiotic susceptibility. For example, DNA-
based tests rely on the knowledge of the resistance mutations and
genes, which is far from being exhaustive. In addition, bacteria
lacking resistance mutations and genes may still be able to
tolerate and survive antibiotic treatments by utilizing many other
mechanisms, some of which are non-genetic (Javid et al., 2014;
Sanchez-Romero and Casadesus, 2014). This obstacle in testing
could be circumvented by detecting the changes in bacterial
physiology caused by antibiotics using flow cytometry (FC)
and fluorescent viability markers, which has been demonstrated
by numerous studies (Gant et al., 1993; Walberg et al., 1997;
Gauthier et al., 2002; Ambriz-Avina et al., 2014). A major
advantage of this methodological approach is that some of the
physiological changes caused by antibiotics occur long before
growth inhibition is observable (1 h vs. 1 or 2 days).
Despite its great potential, FC-based AST (FC-AST) methods
are not yet used for routine clinical applications. The major
difficulty of FC-AST methods is the choice of appropriate
phenotypic markers. For example, changes in membrane
integrity or a loss of membrane potential can be induced even
by sublethal doses of antibiotics but can be reversible and
highly variable (Huang et al., 2015). The best markers are those
associated with the irreversible impairment of cell viability.
The carbonylation of proteins is one such marker because it
is an irreversible process induced by various lethal stressors
(Burcham and Fontaine, 2001; England et al., 2004), including
antibiotic treatment (Kolodkin-Gal et al., 2008; Tkachenko et al.,
2012; Belenky et al., 2015). Recently, Belenky et al. showed that
antibiotic-treated cells characteristically exhibited high levels of
protein carbonylation and a panel of cytotoxic changes that most
probably resulted from oxidative stress (Kohanski et al., 2010;
Belenky et al., 2015). Increased reactive oxygen species levels
result also in carbonylation of other cellular macromolecules
like lipids and nucleic acids (Vemula et al., 2015). Importantly,
carbonylation continues even after cell death (Dalle-Donne et al.,
2006). Therefore, this process is potentially an effective marker
for use in FC-AST applications. Carbonylated molecules react
with fluorescent hydrazides (Ahn et al., 1987), which only enter
cells with compromised membranes. Fluorescent hydrazide-
stained carbonylated molecules can be detected using FC. In a
previous study, we demonstrated that the staining of bacterial
cells with Alexa Fluor R© 633 Hydrazide (AFH) is an indication
that they are not able to recover from lethal stress (Saint-Ruf et al.,
2010).
In this study, we evaluated the potential of the AFH
for use in FC-AST using clinical isolates of Gram-negative
bacteria, Escherichia coli and Pseudomonas aeruginosa, as model
organisms. Bacteria were treated with drugs from three antibiotic
classes: β-lactams, aminoglycosides, and fluoroquinolones. In
addition to the level of carbonylation, we monitored the
following parameters, which have also previously been reported
to vary in antibiotic-treated bacteria (Gant et al., 1993; Gauthier
et al., 2002; Ambriz-Avina et al., 2014): (i) the loss of membrane
integrity using TO-PRO R©-3 dye (Kerstens et al., 2014), which
enters cells with compromised membranes and binds to nucleic
acids; (ii) the loss of membrane potential using DiBAC4(3)
dye, which enters cells with depolarized membranes (Joux and
Lebaron, 2000); and (iii) the alterations of the light scattering
parameters, forward scatter (FSC), and side scatter (SSC), which
indicate the size and protein content of the cells, respectively.
We also evaluated the relevance of FC analysis for deducing
the MIC of β-lactams for clinical isolates of E. coli and
P. aeruginosa.
MATERIALS AND METHODS
Bacterial Strains and Dyes
All bacterial strains were obtained from the bioMérieux
collection Table 1. The following dyes were purchased from
Invitrogen (Carlsbad, CA, USA): Alexa Fluor 633 Hydrazide
(AFH) (absorption 630 nm, emission 645 nm), TO-PRO R©-3
(absorption 642 nm, emission 661 nm), and DiBAC4(3)
(absorption 540 nm, emission 590 nm).
MIC Determination
The lowest concentration of an antibiotic that completely
inhibited visible growth as detected by the unaided eye was
recorded as the MIC. MICs were determined using the broth
microdilution reference method as described by the Clinical and
Laboratory Standards Institute (CLSI) (Patel et al., 2014). MICs
were determined by examining the growth of each strain for
at least three replicates. If two of the three results were the
same, that MIC was used as the composite (“voted”) result.
If the three results differed, the middle result was used. CLSI
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TABLE 1 | Bacterial strains used in this study.
STRAINS ANTIBIOTICS MIC mg/L INTERPRETATION
E. coli
ATCC 25 922 Ampicillin 4 S
Cefoxitin 4 S
Imipenem 0.125 S
Gentamicin 0.5 S
Ciprofloxacin ≤0.0039 S
9203096 Ampicillin 4 S
8812112 Ampicillin 64 R
1110054 Cefoxitin 32 R
1211021 Imipenem 16 R
9607098 Gentamicin 32 R
9210041 Ciprofloxacin 8 R
P. aeruginosa
9203182 Imipenem 1 S
9405057 2 S
9504020 2 S
9412033 4 S
9508040 8 R
0206035 16 R
9207006 16 R
1011314 16 R
9207013 32 R
Escherichia coli 9203096 and Pseudomonas aeruginosa 9203182 strains correspond to
the CDC 2039 and CDC 2087 strains, respectively. These two strains are available at the
Centers for Disease Control, Atlanta, Georgia, USA. Other strains can be obtained upon
request from bioMérieux.
breakpoints were applied to determine category interpretations,
i.e., susceptible or resistant (Patel et al., 2014).
Growth Conditions
The media utilized were lysogeny broth (LB) broth and LB agar
(Difco, Lawrence, KS, USA). Bacteria from a frozen glycerol stock
were inoculated in 10 ml of LB medium in 50 ml centrifuge
polypropylene tubes (Sardtedt, Numbrecht, Germany). Bacteria
were grown in an agitated, liquid LB medium at 37◦C overnight.
This culture was diluted 104-fold in LB medium and grown
again overnight to obtain a starter culture for the antibiotic
treatments.
Antibiotic Treatment Procedure
Fresh LB medium was inoculated with bacteria from the
starter culture to give an initial inoculum of 0.01 OD600,
which was allowed to continue to grow for 1 h, and the
culture was then divided into equal volumes and placed
into tubes in the presence or absence of an antibiotic. The
following antibiotics were used: ampicillin (Totapem) (Unipex,
Paris, France), cefoxitin (Mefoxin) (Sigma-Aldrich, Saint-Louis,
MO, USA), imipenem (Tienam) (bioMérieux Inc Saint-Louis,
MO, USA), gentamicin (Gentalline) (Unipex, Paris, France),
and ciprofloxacin hydrochloride (Ciflox) (MP Biomedical,
Santa Ana, CA, USA). Each sample was incubated for at
least 4 h at 37◦C. Each hour, aliquots of cells were taken,
stained with the dyes described below, and analyzed via
FC. The number of colony forming units (CFUs) were also
counted.
CFU Analysis
To establish the number of CFUs perml of liquid culture, aliquots
of cells, or of the diluted cells, were spread on LB agar plates (agar
15 g/liter) and incubated overnight at 37◦C, and the number of
CFUs was then counted.
Staining Procedure
Based on the concentration of cells, the bacterial culture was
diluted to obtain 107 cells per ml in filtered (pore size, 0.22µm)
phosphate-buffered saline (PBS; Dulbecco Bio-Rad, California
UK) supplemented with one of the dyes. Alternatively, cells
were harvested from culture broth via centrifugation at 8000
× g for 3 min and resuspended at a concentration of 107 cells
per ml in PBS supplemented with one of the dyes. Staining
is not density dependent. Even small number of cells can be
successfully stained. AFH, TO-PRO R©-3 and DiBAC4(3) were
used at concentrations of 2 µg/ml, 0.5 µM, and 10 µg/ml in
PBS, respectively. Cells were incubated at room temperature
for 15 min in the dark. Samples stained with AFH were
washed in PBS before FC analysis, whereas samples stained
with TO-PRO R©-3 or DiBAC4(3) were immediately analyzed
via FC.
Flow Cytometry
We used a BD Accuri C6 FACS system (Becton Dickinson
Biosciences, Franklin Lakes, NJ) to analyze and count the
bacterial cells. Blue laser light (488 nm) was used to analyze
DiBAC4(3) (filters, 530/30 nm). The 640 nm diode was used
to analyze Alexa Fluor 633 hydrazide and TO-PRO R©-3 (filters,
675/25 nm). Samples were run at the rate of 2000 events/s;
50,000 events were collected. Data acquisition and analysis were
performed with BD Accuri C6 and FlowJo software (FLOWJO
LLC, Ashland, Oregon, USA).
ImageStream Cytometry
All samples were acquired on an ImageStreamX MarkII system
(Merck Millipore, Darmstadt, Germany) using a 488 nm laser
(BP 505–560) and a 642 nm laser (BP 640–745). A total of
5000 events were collected for each sample. IDEAS software
(Amnis Corporation, Seattle, WA) was used to analyze the
measurements.
Measurement of the FSC/SSC Areas
The FSC/SSC area for each experiment was estimated from
pseudocolor density-plots FSC/SSC. The density-plots were
saved as a JPEG files and analyzed with ImageJ 1.48 v software.
The perimeter of the cloud of dots was delimited using the
“polygon selection” tool. Isolated dots outside the cloud were not
included in this perimeter (Figure S7), and the defined area was
measured.
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RESULTS
Detection of the Susceptibility of
Escherichia coli Strains to Different
Antibiotics
We first analyzed the susceptibility of E. coli strains to different
antibiotics. These included β-lactam antibiotics (ampicillin,
cefoxitin, and imipenem), which inhibit cell wall biosynthesis; an
aminoglycoside (gentamicin), which inhibits protein synthesis
by binding to the 30S ribosomal subunit; and a fluoroquinolone
(ciprofloxacin), which binds to the DNA-topoisomerase
complexes, resulting in DNA breaks and DNA replication fork
arrest (Kohanski et al., 2010). The MICs of all antibiotics for each
bacterial strain were determined using standard microdilution
AST methods (Table 1). For each experiment, log-phase cultures
of a sensitive strain and of a strain resistant to a given antibiotic
(Table 1) were or were not treated with the given antibiotic
and were then analyzed in a 4-h time course study. The strains
sensitive to a given β-lactam were treated with the MIC of
these antibiotics. The gentamicin-sensitive strain and the
ciprofloxacin-sensitive strain were treated with gentamicin and
ciprofloxacin at 8 × MIC, respectively. The resistant strains
received the same treatment as the sensitive strains.
Measuring the Bacterial Cell Number and
CFU Counts
To evaluate the ability of the antibiotics to kill E. coli and inhibit
growth, we measured the number of bacterial cells via FC, which
scores live and death cells, and the number of CFUs during
4 h (Figure S1A). The number of cells of an untreated sensitive
strain and of an untreated and treated resistant strain increased
in a similar manner over time. The time-dependent increase
in the number of the cells in the treated, sensitive population
was impaired when compared to the change in the untreated
control. The number of sensitive cells in the samples treated
with ciprofloxacin did not increase and was relatively stable over
time. The median number of sensitive cells increased 1.3-fold
after treatment with ampicillin and three-fold after treatments
with cefoxitin and imipenem during first hour of treatment,
after which, it slightly decreased. The number of sensitive cells
in samples treated with gentamicin increased ∼10-fold, which
amounts to approximately three cell doublings, during first hour
of incubation, after which, it remained stable. CFU counts for
the treated, sensitive strain continuously decreased, while CFU
counts for the untreated, sensitive strain and of untreated and
treated, resistant strain increased during the 4 h of incubation
for all antibiotics (Figures S1A,B). Therefore, it can be concluded
that the fraction of cells unable to grow and form colonies on LB
plates increased within the sensitive populations after treatment
with the antibiotics. Even cells that succeeded in dividing during
the first hour of treatment were unable to give rise to colonies.
Light Scattering Profiles FSC and SSC
After incubation with ampicillin, the light scattering profile of
the treated, sensitive E. coli strain became dispersed due to
the appearance of cells of different shapes and sizes relative
to the profile of the untreated control (Figure 1, Figures S2,
S4). After 1 h of incubation, cells with sizes ranging from 4 to
166 µm, along with numerous filamentous cells, were observable
in images acquired with the ImagestreamX MarkII FC system.
After 2 h, a population of cells smaller than those of the untreated
sample appeared alongside the population of larger cells (Figure
S4B). These observations suggest that many filamentous cells or
large cells may have undergone lysis, divided and given rise to
smaller cells or shrunk. As a measure of the variation of the
light scattering profiles, we calculated the FSC (or SSC) ratio,
which is equal to the mean value of the FSC (or SSC) intensity
of the treated cells divided by the mean value of the FSC (or
SSC) intensity of the untreated cells. After 2 h of treatment
with ampicillin, imipenem, gentamicin or ciprofloxacin, the FSC
ratios of the sensitive strain were significantly (t-test, p < 0.05)
higher (2 to 10-fold depending on the antibiotic) than the FSC
ratios of the resistant strains. Only the FSC ratio of the sensitive
strain treated with cefoxitin was not significantly different than
the FSC ratio of the resistant strain. The SSC ratios of the sensitive
strain were significantly (t-test, p < 0.05) higher (two and six-
fold) than those of the resistant strains after only 2 or 3 h of
treatment with ampicillin and ciprofloxacin.
Because the changes in the light scattering profile caused by
the antibiotics within the treated, sensitive populations occur
in two opposite directions, i.e., some cells were smaller and
some larger than the untreated cells, an analysis of the FSC and
SSC mean intensity values can lead to the underestimation of
these changes. Therefore, for a better estimation of the light
scattering variations, we also calculated the area of scattering on
density dot-plots for FSC/SSC for each experiment. Afterward,
we calculated the ratio of the area of scattering of the treated
sample vs. that of the corresponding untreated sample. Based on
this calculation, we observed a significant difference in the light
scattering of the cells treated with all tested antibiotics after 1 or
2 h (t-test, p = 0.03). These results indicate that measurements
of the dispersion of the light-scattering profiles of the cells after
antibiotic treatment allow for the estimation of the susceptibility
of a strain to an antibiotic (Figure 2).
Autofluorescence
We observed that the antibiotic treatments of the sensitive
E. coli strain induced a weak far-red cellular autofluorescence.
Less than 5% of the treated cells had a higher autofluorescence
than the autofluorescence of the untreated cells as detected
with the FC parameters used to measure the fluorescence of
AFH and TO-PRO R©-3 (excitation at 633 nm with bandpass
filters of 660/20 nm; Figure 2). In contrast, the antibiotics
induced a substantial green autofluorescence (excitation at
488 nm with bandpass filters of 530/30) in the sensitive
cells. 25 to 35% of the sensitive cells treated with the three
β-lactams and 5 to 15% of the sensitive cells treated with
gentamicin and ciprofloxacin had autofluorescence intensities
10-fold higher than the untreated cells (Figure 2). Treating
resistant bacterial strains with antibiotics did not increase cellular
autofluorescence. While the antibiotic-induced autofluorescence
was low to interfere with the measurements of fluorescence the
antibiotic-treated cells stained with AFH and TO-PRO R©-3, it
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FIGURE 1 | Effects of antibiotics on the light scatter SSC and fluorescence intensity distribution. Density-plots SSC vs. fluorescence intensity of bacterial
samples treated, or not, with ampicillin, cefoxitin, imipenem, gentamicin, and ciprofloxacin, during 2 h and stained with AFH, TO-PRO®-3, and DiBAC4(3). The vertical
bars in the density-plots of the untreated samples and the density-plots of the treated samples are at the same place. (A) E. coli ATCC25922 strain, which is sensitive
to all the studied antibiotics. (B) E. coli strains resistant to the one of the tested antibiotics.
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FIGURE 2 | Monitoring alterations of the E. coli strains treated with different antibiotics via flow cytometry. Time course study of sensitive (ATCC25922
strain sensitive to all the studied antibiotics) and resistant strains treated, or not, with ampicillin, cefoxitin, imipenem, gentamicin, and ciprofloxacin. This figure shows
the ratios of the mean FSC intensity of the antibiotic treated samples/the mean FSC intensity of the untreated samples; the ratios of the mean SSC intensity of the
treated samples/the mean SSC intensity of the untreated samples; the ratios of the area of the density plots for FSC/SSC (FSC/SSC area) of the antibiotic-treated
samples/the FSC/SSC area of the untreated samples; and the percentage of fluorescent cells stained with AFH, TO-PRO®-3 and DiBAC4(3) of the antibiotic-treated
samples, all relative to incubation time. The percentage of fluorescent cells in treated samples was determined using the fluorescence of the untreated samples as a
baseline. , sensitive antibiotic-treated strain, , resistant antibiotic-treated strain, , autofluorescence of the sensitive antibiotic-treated strain, ,
autofluorescence of the antibiotic-treated resistant strain (Ex 640 nm, Em 675 nm ± 25 nm for AFH and TO-PRO®-3; Ex 488 nm, Em 530 nm ± 30 nm for
DiBAC4(3)). Each value represents the mean value obtained from four independent experiments. The error bars correspond to the standard error of the mean.
could interfere with the measurement of the green fluorescence
of antibiotic-treated cells stained with DiBAC4(3).
Antibiotic-Induced Changes Revealed by
Staining with AFH, TO-PRO®-3, and
DIBAC4
We stained treated and untreated E. coli cells with the dyes
AFH, TO-PRO R©-3, and DiBAC4(3), and compared the changes
in the distributions of fluorescent signal intensity using FC
(Figures 1, 2, Figures S2, S3). First, we analyzed the mean
fluorescence intensity (MFI) of cell populations treated or
untreated with the antibiotics during 5 h and stained with the
AFH and TO-PRO R©-3 (Figure S3). We found a increase of the
MFI of the sensitive cell population treated with the antibiotics
for both dyes. An increase of the MFI for AFH stained cells
correlated with increasing mortality (CFU). However, this was
true for TO-PRO R©-3 only during first 2 h of incubation with
antibiotic, because of the MFI decrease after 2 h of incubation.
Second, we analyzed the percentage of stained cells to evaluate
number of cells impacted by the antibiotic. The percentage of
cells that were fluorescent due to the antibiotic treatment were
calculated using the fluorescence of untreated stained cells as a
baseline fluorescence. For each antibiotic, the percentage of cells
from the resistant strains stained with the three dyes did not
exceed 3%.
A substantial increase in the percentage of fluorescent
cells stained with AFH was observed for the sensitive strain
after 1 h of treatment with all antibiotics (Figure 2). After
2 h of incubation with ampicillin, cefoxitin, and imipenem,
the percentage of fluorescent cells reached plateaus of 80 and
60%, respectively. This is in accordance with observations
that this strain survives cefoxitin and imipenem treatment
better than it does ampicillin treatment (Figure S1). A similar
plateau, at ∼30%, was observed for the cell populations
treated with ciprofloxacin, while percentage of fluorescent
cells treated with gentamicin continuously increased up to
40%. The different kinetics of AFH staining associated with
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the different antibiotics probably reflects different kinetics
of membrane damage and carbonylation of macromolecules,
which are both required to obtain a fluorescent signal using
this dye.
As with AFH, a substantial increase of the percentage of cells
stained with TO-PRO R©-3 was observed for the sensitive strain
after 1 h of treatment with all antibiotics (Figure 2). The patterns
of staining with TO-PRO R©-3 after treatment with all antibiotics
were similar to those obtained with the AFH treatment except
that the percentage of stained cells was 10 to 20% higher in the
β-lactam-treated samples.
The results obtained with DiBAC4(3) staining were different
than the results from the two other dyes. A substantial
increase in the percentage of stained cells was observed for the
sensitive strain after 1 h of incubation with β-lactams but not
with gentamicin or ciprofloxacin (Figure 2). Plateaus of 80%
fluorescent cells were observed after 2 h of incubation with the
3 β-lactams. For the gentamicin treatment, 20 and 40% of the
cells were stained after 3 and 4 h, respectively. After 4 h of
incubation with ciprofloxacin, only 25% of cells were stained.
Taken together, our results indicate that AFH and TO-PRO R©-3
are better markers than DiBAC4(3) for use in FC-AST for a wide
range of antibiotics.
Correlation between the MIC of Ampicillin
and Flow Cytometry Data
To evaluate the relevance of the FC data for deducing the MIC of
antibiotics, we used ampicillin as a model antibiotic and, three E.
coli clinical isolates, two with an MIC of 4 mg/L and one with an
MIC of 64 mg/L. We treated log-phase cultures of these strains
with various concentrations of ampicillin: 0, 1, 2, 4, 8, 16, 32,
64, and 128 mg/L for 4 h. Aliquots of cells were harvested every
hour, stained with AFH and TO-PRO R©-3 and analyzed with FC
(Figure 3 and Table S1).
For all strains, less fluorescent cells were stained with
AFH when they were treated with ampicillin below the 0.5
MIC. This shows that detection of carbonylation of cellular
macromolecules by AFH is powerful method, which allows
revealing the physiological changes caused by antibiotics before
complete growth inhibition. Two percent of the cells and 30%
were stained when the strains with an MIC of 4 mg/L were
treated with 1 and 2 mg/L of ampicillin at least 2 h, and less
than 5% were stained when the strain with an MIC of 64 mg/L
was treated with 1, 4, 8, and 16 mg/L of ampicillin, while 30%
of the cells were stained when it was treated with 32 mg/L of
ampicillin. For all strains, ≥ 60% of cells were stained with AFH
when they were treated with ampicillin at a level ≥ the MIC at
least 2 h. When comparing the two strains having an MIC of
4 mg/L, the percentage of cells stained with AFH was different
after treatment with 4 mg/L of ampicillin. This discrepancy
could indicate that the MIC of the two strains is slightly
different.
For all strains, except the one having an MIC of 64 mg/L
MIC treated with 32 mg/L of ampicillin, few cells were stained
with TO-PRO R©-3 when they were treated with ampicillin at a
level < 0.5 × MIC (Figure 3). Interestingly, the percentage of
fluorescent cells from the strain having an MIC of 64 mg/L,
when treated with 32 mg/L of ampicillin, reached 80% after 1 h,
followed by a constant decrease to 30% at 4 h. This suggests
that the membrane permeabilization allowing TO-PRO R©-3 to
enter the cells and interact with DNA is reversible. Cells probably
recovered over time through the activity of the β-lactamase
expressed by this strain. For all strains, ≥ 70% of cells were
stained with TO-PRO R©-3 when they were treated with ampicillin
at a level ≥ the MIC. For AFH and TO-PRO R©-3, the percentage
of stained cells was 5–20% lower when samples were treated with
the highest concentrations of ampicillin than when they were
treated with the concentration just above the MIC (Figure 3).
This could have resulted from an increase in cell lysis at the high
concentrations of ampicillin.
Each tested strain showed a particular forward scattering
profile (FSC). For the ATCC25922 strain, with an MIC of
4mg/L, the FSC ratio (treated/untreated cells) increased with
the concentration of ampicillin and with incubation time, except
for the samples treated with 8mg/L of ampicillin. At this
concentration, the FSC ratio increased two-fold after 1 h of
incubation and then decreased. The FSC ratio of the cells treated
at their MIC was ∼4. For the 92030096 strain, with an MIC of
4mg/L, the increases in the FSC ratio were higher after treatment
with 2 and 4mg/L of ampicillin than they were after treatment
with the other concentrations (1, 8, 16, 32, 64, and 128mg/L).
For the 8812112 strain, with an MIC of 64 mg/L, the FSC ratios
of the cells were higher after treatment with 32 and 64 mg/L
of ampicillin than after treatment with 128 mg/L of ampicillin.
This result was due to the presence of several subpopulations of
cells among the treated cells that were larger or smaller than the
untreated cells.
An analysis of the FSC/SSC areas shows that for all strains, the
areas increased when the cells were treated with a concentration
of ampicillin higher than the 0.5 MIC. For the 8812112 strain,
with an MIC of 64 mg/L, the FSC/SSC area increased also after
treatments with 0.25 MIC.
Finally, we examined the correlation between the MIC of
ampicillin for the 3 strains, the ampicillin treatments and
the FC measurements. To accomplish this, an X[MIC] value
was attributed to each experiment, i.e., one strain treated
with one concentration of ampicillin over 4 h. X[MIC] values
were determined from the MIC of the strain and from the
concentration of ampicillin used in the experiment. If for a given
strain the concentration of ampicillin used in the experiment was
≥ the MIC, then X[MIC] was 1. If the concentration of ampicillin
used in the experiment was below the MIC, then X[MIC] was —1.
Four Y[FC] values were calculated from the FC results obtained
by measuring the following variables: the percentage of cells
stained with (i) AFH or (ii) TO-PRO R©-3, the change in (iii)
FSC or the change in (iv) FSC/SSC area following the antibiotic
treatment for each experiment. The FC results obtained were
analyzed in Two ways. First, to evaluate how the MIC and the
concentration of ampicillin used affected the FC results over
the duration of the experiment, we calculated the areas under
the curves (AUCs) of the FC results vs. the time of incubation
with ampicillin (Figure 3). For each FC parameter, the coefficient
of correlation (R2) between the X[MIC] and Y[FC] AUC was
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FIGURE 3 | Monitoring alterations of the E. coli strains treated with a range of ampicillin concentrations via flow cytometry. The E. coli 7705035 (MIC =
4 mg/ml), 9203096 (MIC = 4 mg/ml), and 8812112 (MIC = 64 mg/ml) strains were treated with a range of ampicillin concentrations (0, 1, 2, 4, 8, 16, 32, and 64
mg/L). This figure shows the ratios of the mean FSC intensity of the ampicillin treated samples/the mean FSC intensity of the untreated samples, the ratios of the
FSC/SSC area of the ampicillin treated samples/the FSC/SSC area of the untreated samples and the percentage of fluorescent cells stained with AFH and
TO-PRO®-3, all relative to incubation time. Each value represents the mean value obtained from four independent experiments. The error bars correspond to the
standard error of the mean.
calculated for all experiments (Table 2A). Second, to evaluate
how the correlations between AFH and TO-PRO R©-3 staining,
FSC, FSC/SSC area and MIC change over time, we calculated
R2-values between all X[MIC] and Y[FC] comparisons at each
time point for all experiments (Table 2B). Both analyses showed
strong correlations between MIC values and AFH staining, TO-
PRO R©-3 staining, and FSC/SSC area. The highest correlations
were observed with AFH staining, i.e., R2-values were 0.83 for
the AUCs (Table 2A) and were up to 0.85 after 2 h of incubation
(Table 2B). The correlations between the MIC values and FSC
were the lowest, i.e., 0.18 for the AUCs (Table 2A) and 0.39 after
1 h of incubation, after which, the correlations decreased further
(Table 2A).
Thus, these results show that there is a strong correlation
between the MIC of a strain and the FC results obtained after
ampicillin treatment. Furthermore, it is possible to evaluate the
MIC of a strain based on flow cytometry data obtained using the
dyes AFH, TO-PRO R©-3 and the light scattering data represented
by the FSC/SSC area after 1 h of treatment with a range of
ampicillin concentrations.
Detection of the Susceptibility of the
Pseudomonas aeruginosa to Imipenem
We decided to evaluate if the FC-AST can be used for bacterial
species other than E. coli. For this, we tested the susceptibility
of P. aeruginosa strains to imipenem. This choice was guided
by the fact that high levels of antibiotic resistance makes
P. aeruginosa one of the most important nosocomial pathogens
(Zilberberg et al., 2010). Imipenem is frequently prescribed as
a first-line therapy. However, 15 to 20% of P. aeruginosa cells
are or become resistant during treatment with this antibiotic
(Zilberberg et al., 2010). We first tested the susceptibility of
log-phase cultures of two P. aeruginosa strains (one sensitive,
one resistant) after treatment with imipenem at 2 mg/L, which
corresponds to the MIC of the sensitive strain. Similar to
our previous observations with E. coli (Figure 2), the light
scattering profile of treated P. aeruginosa cells became dispersed,
revealing a heterogeneous cell population (Figure S5A). A large
proportion of the treated cells had a higher SSC and FSC
value than the untreated cells. Less than 5% of the treated
cells had a level of far-red autofluorescence greater than that
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TABLE 2 | Correlations between MIC values, dye staining, and light
scattering signals for the ampicillin-treated E. coli strain.
A
AUC 1×MIC R2
AFH 0.83
TO-PRO®-3 0.75
Area FSC/SSC 0.65
FSC 0.18
B
Time (h) AFH TO-PRO®-3 FSC/SSC area FSC
R2 R2 R2 R2
1 0.75 0.66 0.51 0.39
2 0.85 0.72 0.66 0.25
3 0.85 0.81 0.68 0.25
4 0.8 0.76 0.54 0.25
To check if the MICs obtained using the standard microdilution assay corresponds to
a threshold values impacting the FC measurements, each experiment was described
by 2 variables: X[MIC] and Y[FC]. X[MIC] = 1 if the concentration of ampicillin used in
the experiment ([Amp]) was ≥ 1 ×MIC and X[MIC] = −1 if [Amp] was < 1 ×MIC. Y[FC]
corresponds to the FC data collected for each parameter for each experiment. (A) Y[FC]
corresponds to the areas under the curves (AUCs) of the FC results relative to the time of
incubation. (B) Y[FC] corresponds to the FC values obtained at each hour of incubation.
The correlation coefficients (R2 ) between X[MIC] and Y[FC] for each measured parameter
(% of cells stained with AFH or TO-PRO®-3, ratios of FSC and the ratios FSC/SSC areas)
were calculated for all experiments. Two-tailed P < 0.0001.
of the untreated cells (Figure S5A). Approximately 15% of
the treated cells had green autofluorescence intensity levels
that were 10-fold higher than those of the untreated cells
(Figure S5A).
Several studies have reported an intrinsic permeability of
this bacterium to the viability dyes, which makes FC viability
testing difficult (Gauthier et al., 2002; Huang et al., 2015).
Indeed, we observed that the fluorescent signals of the untreated
P. aeruginosa cells shifted slightly after staining with AFH and
substantially after staining with TO-PRO R©-3 when compared
with the fluorescent signals of the unstained samples (Figure
S5B). However, these background fluorescences did not impair
the measurements of imipenem susceptibility because a much
greater increase in fluorescence was observed for the antibiotic-
treated populations relative to that of the untreated control
populations.
As for the E. coli strains, a significant increase of the MFI
of the cell population treated with the MIC of imipenem and
stained with all dyes was observed (Figure S5C). The percentage
of cells that were fluorescent due to the antibiotic treatment
was calculated by using the fluorescence of the untreated,
stained cells as a baseline. A large increase in the percentage
of fluorescent cells stained with AFH and TO-PRO R©-3 was
observed after treatment with imipenem, which is similar to
our data for E. coli (Figure S5A). However, for DiBAC4(3)
staining, only 20% of the P. aeruginosa cells were stained after
1 and 2 h of incubation with imipenem (Figure S5A), which
is much less than the 70% staining of treated E. coli cells
(Figure 2).
Next, we analyzed nine strains of P. aeruginosa displaying
MICs for imipenem that ranged between 1 and 32 mg/L
(Table 1). Each strain was grown in LB supplemented with (0,
1, 2, 4, 8, 16, 32, or 64 mg/L of imipenem) for 4 h, stained
with AFH and TO-PRO R©-3, and analyzed with FC (Figure 4
and Table S2). After 1 h of incubation with concentrations of
imipenem < 0.5 × MIC, 1–20% of cells were stained with AFH
and 1–40% with TO-PRO R©-3. For some strains, the percentage
of stained cells increased with the time of incubation. After 1 h
of treatment with ≥ 0.5 × MIC of imipenem, the percentage
of fluorescent cells stained with AFH and TO-PRO R©-3 reached
a plateau greater than 40 and 50%, respectively, for all tested
strains.
The FSC light scattering profiles of the P. aeruginosa strains
were strain dependent (Figure 4). This was also observed for
the E. coli strains (Figure 2). However, the calculation of the
FSC/SSC areas was less informative for P. aeruginosa than it
was for E. coli because changes in FSC and SSC occurred even
when the cells were treated with imipenem concentrations below
0.25×MIC.
Finally, we calculated correlations between the MIC of
imipenem for different strains of P. aeruginosa and the values
analyzed via FC (i.e., AFH and TO-PRO R©-3 staining result,
FSC profiles and the FSC/SSC areas) (Table 3) as we did for
E. coli (Table 2). The R2-values (two-tailed P < 0.0001) were
0.7, 0.53, 0.28, and 0.34 for AFH, TO-PRO R©-3, FSC, and
the FSC/SSC area, respectively. As most of strains showed
a high increase of fluorescent cells even at 0.5 × MIC of
imipenem, we also calculated the X[MIC] variables by replacing
the MIC values with the 0.5 × MIC values (Table 3A).
After doing so, the R2-values were 0.80, 0.75, 0.45, and
0.33 for AFH, TO-PRO R©-3, FSC, and the FSC/SSC area,
respectively.
Calculations using the FC values at the different time points
(Table 3B) showed that R2-values were maximal after 1 h of
treatment: AFH = 0.82 and TO-PRO R©-3 = 0.80. After this
time point, R2-values decreased somewhat. R2-values were 0.73
and 0.68 for AFH and TO-PRO R©-3, respectively, after 3 h of
treatment. This decrease is due to the increase in stained cells
in the samples treated with a concentration of imipenem below
0.5 × MIC (Figure 4). Therefore, we showed that it is possible
to evaluate the MIC of the P. aeruginosa strains after 1 h of
treatment with imipenem using FC and fluorescent dyes.
Flow Cytometers
We did not observe more than 90% of the cells stained with the
tested dyes, while at least 99.9% of the cells were unable to give
a CFU after antibiotic treatments (Figure S1B). This discrepancy
was mostly due to the threshold of detection of the BD Accuri
C6 FC system (BD Biosciences) used for the study. Preliminary
experiments with the Gallios FC system (Beckman Coulter)
showed that higher fluorescence intensities can be obtained
than with BD Accuri C6. For the same experiment, ∼10%
more stained cells can be detected with the Gallios than with
Accuri (data not shown). The small number of unstained cells
could be dead “phantom” cells without intracellular contents,
unculturable cells or persister cells.
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FIGURE 4 | Monitoring alterations of the P. aeruginosa strains treated with a range of imipenem concentrations via flow cytometry. P. aeruginosa strains
having different MICs (see Table 1) for imipenem were treated with a range of concentrations of imipenem (1, 2, 4, 8, 16, 32, or 64 mg/L). This figure shows the ratios
of the mean FSC intensity of the imipenem-treated samples/the mean FSC intensity of the untreated samples, the ratios of the FSC/SSC area of the imipenem-treated
samples/the FSC/SSC area of the untreated samples, and the percentage of fluorescent cells stained with AFH and TO-PRO®-3, all relative to incubation time. Each
value represents the mean value obtained from four independent experiments. The error bars correspond to the standard error of the mean.
DISCUSSION
In this study we assessed whether FC and fluorescent dyes can be
used to rapidly and reliably diagnose the antibiotic susceptibility
of the bacterial pathogens E. coli and P. aeruginosa. The first
conclusion from this study is that the light scatter signals, FSC
and SSC, are highly dependent on the bacterial strain used.
However, light scatter signals allow for the detection of the
heterogeneity of morphological changes and proteins content
in populations of antibiotic-treated cells (Gauthier et al., 2002;
Ambriz-Avina et al., 2014). We found that the analysis of
scattering area in the dot-plots of FSC/SSC allowed for a useful
quantification of antibiotic-induced morphological changes. In
this study, we observed a high heterogeneity for E. coli and
P. aeruginosa antibiotic-treated cells. For this reason, light
scatter signals could be considered in combination with others
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TABLE 3 | Correlations between MIC values, dye staining, and light
scattering signals for the imipenem-treated P. aeruginosa strain.
A
AUC X[MIC]1 R
2 X[MIC]2 R
2
sAFH 0.70 0.80
TO-PRO®-3 0.53 0.75
Area FSC/SSC 0.28 0.45
FSC 0.34 0.33
B
Time (h) AFH TO-PRO®-3 FSC/SSC area FSC
X[MIC]2 R
2 X[MIC]2 R
2 X[MIC]2 R
2 X[MIC]2 R
2
1 0.82 0.8 0.51 0.4
2 0.81 0.70 0.52 0.17
3 0.73 0.68 0.56 0.2
4 0.68 0.69 0.53 0.28
As for E. coli and ampicillin in Table 2, each experiment with P. aeruginosa and imipenem
was described by 2 variables: X[MIC] and Y[FC], except that two X[MIC] values were
calculated. X[MIC]1 = 1 if the concentration of imipenem used in the experiment ([Imip])
was ≥ 1 × MIC and X[MIC]2= 1 if the [Imip] was ≥ 0.5 ×MIC. X[MIC]1 = −1 if the [Imip]
was < 1×MIC and X[MIC]2 =−1 if the [Imip] was < 0.5×MIC. (A) R
2- values calculated
between X[MIC]1 and Y[FC] (AUC). R
2-values calculated between X[MIC]2 and Y[FC] (AUC).
(B) R2-values calculated between the X[MIC]2 and Y[FC] values for each hour of incubation.
Two-tailed P < 0.0001.
factors to avoid underestimating the effects of some antibiotics.
Cells sorting and an analysis of the morphologically different
subpopulations may well provide new information regarding the
modes of action of antibiotics and the mechanisms of resistance.
The second conclusion we reached is that cell staining with
the fluorescent dyes are more reliable indicators for antibiotic
susceptibility than are light scatter signals. We tested the
potential of 3 dyes for use in FC-AST: AFH, TO-PRO R©-3, and
DiBAC4(3). AFH and TO-PRO R©-3 are particularly suitable for a
FC-AST because they have a far-red fluorescence, which does not
increase significantly in unstained cells treated with the different
antibiotics. However, green autofluorescence does increase in
antibiotic treated cells (Renggli et al., 2013) and this can interfere
with the detection of signals from dyes, such as DiBAC4(3)
that produce a green fluorescence with some antibiotics and
in some bacterial strains. For example, while the number of
DiBAC4(3) stained cells increased significantly in populations of
E. coli strains treated with the β-lactams and P. aeruginosa strains
treated with imipenem, the increase was low and was difficult to
distinguish from the green autofluorescence of the E. coli cells
treated with the gentamicin and ciprofloxacin.
For all of the different combinations of sensitive bacterial
strains and antibiotics analyzed, we observed a significant
increase in the cells stained with AFH and TO-PRO R©-3.
However, the percentage of stained cells depended on the
antibiotic used. When cells were treated with 1 × MIC of β-
lactam, most of the cells were already stained with these two dyes
after 1 h. However, a much lower percentage of the cells treated
with gentamicin and ciprofloxacin was stained by these dyes. We
also observed that the staining of cells treated with the MIC of
gentamicin and ciprofloxacin was lower in fluorescence intensity
and detectable after a longer time of treatment using the BD
Accuri C6 cytometer than when it was treated with higher doses.
One possible explication is that the impaired protein synthesis
caused by gentamicin and the impaired DNA replication and
transcription caused by ciprofloxacin result in slower membrane
permeabilization and lower carbonylation of macromolecules
than in cells treated with β-lactams.
The FC data show that the percentage of antibiotic-treated
cells stained with TO-PRO R©-3 was higher than the percentage of
cells stained with the AFH (5–15%). This could be explained by
the fact that antibiotics can cause membrane damage, allowing
TO-PRO R©-3 to enter the cells without killing them. Indeed, it
has been reported that live cells with damaged membranes that
are permeable to DNA-binding dyes can recover (Frankenberg-
Schwager et al., 1975; Ruiz and Silhavy, 2005). This could explain
why we found similarly high numbers of sensitive E. coli cells
of the ATCC25922 strain stained with TO-PRO R©-3 following
treatments with ampicillin, cefoxitin or imipenem even though
the CFU analysis showed that ampicillin killed more cells (99%)
than cefoxitin and imipenem (85 and 95%, respectively), after
4 h of treatment. Staining with AFH showed a better correlation
with the CFU count because it was higher with ampicillin (80%
of cells stained) than with cefoxitin or imipenem treatment
(60% of cells stained). Transient membrane permeabilization
and cell recovery can also explain the fact that most of the
cells of from an E. coli resistant strain treated with a sub-
lethal concentration of ampicillin were transiently stained with
TO-PRO R©-3. Therefore, the third conclusion that we can draw
from our results is that AFH is more suitable for FC-AST than
TO-PRO R©-3 and probably than all other DNA-interacting dyes.
This observation supports our hypothesis that carbonylation,
which has not previously been tested for use in FC-AST studies,
is a good indicator for detecting the susceptibility of bacteria to
antibiotics.
Finally, we evaluated the possibility that FC-AST can be used
to determine the MIC of different bacterial strains. For this we
compared FC-AST data obtained from bacterial strains having
different MICs. We tested ampicillin for E. coli and imipenem
for P. aeruginosa, using AFH and TO-PRO R©-3 as the dyes.
For E. coli, sub-MIC ampicillin treatment (<0.5 MIC) resulted
in a small number of cells being stained with AFH and TO-
PRO R©-3, while treatments at levels ≥ the MIC increased the
number of stained cells by >50% and increased the dispersion
of the light scatter signals (area of the density dot plots of
FSC/SSC). The correlation between MIC and staining with each
dye was strong: the R2 was 0.75 after 1 h of incubation and
0.85 after 2 h of incubation. These results indicate that the
inhibition of growth is associated with the rapid killing of most of
the cells.
Determining the MIC for the imipenem-treated P. aeruginosa
strains was less straightforward because a substantial number of
cells were stained with AFH and even more with TO-PRO R©-
3 at levels of imipenem ≤ 0.25 × MIC. This could be due to
the previously reported artifactual enhancement of membrane
permeability due to the interaction of the dye with the outer
membrane (Gauthier et al., 2002). This could also be due to a
growth bistability of the cells as defined byDeris et al. (2013), who
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showed that isogenic E. coli cells can coexist in growing and non-
growing states over a broad range of antibiotic concentrations
below the MIC. We observed that the number of CFUs in the
population of P. aeruginosa cells treated with ≤ 0.25 × MIC
was slighty lower than those of the untreated population (Figure
S5). However, despite these known difficulties in analyzing
P. aeruginosa via FC, the correlation between MIC and AFH
staining was high, i.e., R2 = 0.70 after 1 h of treatment. We also
observed that the increase in the percentage of cells stained with
AFH was well correlated with the treatment of P. aeruginosa cells
with imipenem at 0.5 × MIC (R2 = 0.80). A larger variety of
strains should be used to confirm that 0.5×MIC is the threshold
that can be used to interpret FC-AST results for P. aeruginosa.
Our final conclusion is that FC-AST based on AFH staining
could be used to determine the MIC of different bacterial
strains. AFH-based FC-AST could even allow for more accurate
measurements of MIC to be obtained as we observed noticeable
differences in the FC results for E. coli and P. aeruginosa
strains that have previously been shown to have the same MIC
based on the standard microdilution assay. Our preliminary data
with Staphylococcus aureus suggest that FC-AST based on AFH
staining could be also used to evaluate antibiotic susceptibility
of the Gram-positive bacteria (Figures S8, S9; Supplementary
results 1). Therefore, it is possible that growth-based MICs could
be substituted with a new FC-based standard, e.g., the minimum
concentration of antibiotic needed to obtain a large increase in
the number of cells stained with a dye after 2 h of incubation.
The standardization of multi parametric analyses combining dye
staining with morphological data obtained via light scattering
signals and the use of ImageStream technology could allow
for the development of a fast and reliable AST procedure.
Finally, the utilization of new fluorescent reporters allowing
the detection of metabolic changes that occur as a result of
treatment with antibiotics could further improve the reliability of
FC-AST.
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